In 2020, pre-filled syringes of the influenza vaccine SKYCELL by SK bioscience Co., Ltd. was the leading pharmaceutical product in South Korea based on a production value of about 164.7 billion South Korean won. It was followed by the K-CAB tablet against chronic acid reflux (GERD) by HK inno.N Co. (formerly known as CJ HealthCare) and the blood clot medication Plavix tablet made by Handok Pharm. Co.
Leading pharmaceutical products in South Korea in 2020, by production value (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Leading pharmaceutical companies South Korea 2020, by production value
- Increment share among life sciences companies in India 2016-2019
- Therapeutic sectors for drug products South Korea 2019, by production value
- Number of employees in the South Korean pharmaceutical industry 2019, by sector
- Share of employees in the South Korean pharmaceutical industry 2014, by sector
- Top ten pharmaceutical merger and acquisition deals by value 2014
- Services from pharma companies to manage disease or health issue 2013
- Leading global pharmaceutical risers based on share price 2021
- Preferred services from a pharmaceutical company 2013
- Global proportion of researchers at pharma companies with dual relationships 2014
- Digital health strategy priorities for pharma companies 2013
- Best time for pharmaceutical companies to contact patient 2013
- Leading five global anti-viral products by revenue 2017 and 2024
- Importance of digital health strategy objectives for pharma companies 2013
- Responsibility of pharmaceutical firms to provide complementary services 2013
- Satisfaction with own cost for healthcare in the U.S. 2002-2020
- 1-year probability of default median for public U.S. healthcare industries 2020-2021
MFDS (South Korea). (December 30, 2021). Leading pharmaceutical products in South Korea in 2020, by production value (in billion South Korean won) [Graph]. In Statista. Retrieved August 19, 2022, from https://www.statista.com/statistics/1073848/south-korea-leading-pharmaceutical-products-by-production-value/
MFDS (South Korea). "Leading pharmaceutical products in South Korea in 2020, by production value (in billion South Korean won)." Chart. December 30, 2021. Statista. Accessed August 19, 2022. https://www.statista.com/statistics/1073848/south-korea-leading-pharmaceutical-products-by-production-value/
MFDS (South Korea). (2021). Leading pharmaceutical products in South Korea in 2020, by production value (in billion South Korean won). Statista. Statista Inc.. Accessed: August 19, 2022. https://www.statista.com/statistics/1073848/south-korea-leading-pharmaceutical-products-by-production-value/
MFDS (South Korea). "Leading Pharmaceutical Products in South Korea in 2020, by Production Value (in Billion South Korean Won)." Statista, Statista Inc., 30 Dec 2021, https://www.statista.com/statistics/1073848/south-korea-leading-pharmaceutical-products-by-production-value/
MFDS (South Korea), Leading pharmaceutical products in South Korea in 2020, by production value (in billion South Korean won) Statista, https://www.statista.com/statistics/1073848/south-korea-leading-pharmaceutical-products-by-production-value/ (last visited August 19, 2022)